Clinical trial
First-In-Human Intracoronary Dual-modal Optical Coherence Tomography and Fluorescence Lifetime Imaging (OCT-FLIM) In Patients Undergoing Percutaneous Coronary Intervention
NCT04835467 is registered in ClinicalTrials.gov with Korea University Guro Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- First-In-Human Intracoronary Dual-modal Optical Coherence Tomography and Fluorescence Lifetime Imaging (OCT-FLIM) In Patients Undergoing Percutaneous Coronary Intervention
- Lead sponsor
- Korea University Guro Hospital
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- February 14, 2022
- Completion date
- October 31, 2023
- Enrollment
- 40 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atheroscleroses, coronary, atherosclerosis, atherosclerosis coronary artery with angina pectoris, atherosclerotic plaque, thin-cap fibroatheroma